Detalhe da pesquisa
1.
DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma.
PLoS Genet
; 20(3): e1011216, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512964
2.
Tumor hepatitis B virus RNA identifies a clinically and molecularly distinct subset of hepatocellular carcinoma.
PLoS Comput Biol
; 17(2): e1008699, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33561166
3.
A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma.
Oncologist
; 25(11): 925-e1603, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32400000
4.
Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma.
Oncologist
; 25(12): e1837-e1845, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32154962
5.
Sampling strategies to capture single-cell heterogeneity.
Nat Methods
; 14(10): 967-970, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28869755
6.
Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer.
Nat Chem Biol
; 14(8): 768-777, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29942081
7.
Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series.
Cancer
; 125(18): 3234-3241, 2019 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31154669
8.
Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis.
J Hepatol
; 71(4): 742-752, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31195063
9.
An Optimized Chromatographic Strategy for Multiplexing In Parallel Reaction Monitoring Mass Spectrometry: Insights from Quantitation of Activated Kinases.
Mol Cell Proteomics
; 16(2): 265-277, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27940637
10.
Hybrid Capture-Based Tumor Sequencing and Copy Number Analysis to Confirm Origin of Metachronous Metastases in BRCA1-Mutant Cholangiocarcinoma Harboring a Novel YWHAZ-BRAF Fusion.
Oncologist
; 23(9): 998-1003, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29622700
11.
Identification of Chemical Inhibitors of ß-Catenin-Driven Liver Tumorigenesis in Zebrafish.
PLoS Genet
; 11(7): e1005305, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26134322
12.
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice.
J Hepatol
; 67(6): 1194-1203, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28733220
13.
HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation.
Cancer Cell
; 12(2): 108-13, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17692803
14.
HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity.
Cancer Cell
; 11(4): 335-47, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17418410
15.
Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinoma.
Cell Rep
; 43(2): 113678, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38236773
16.
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update.
J Clin Oncol
; 42(15): 1830-1850, 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502889
17.
New Opportunities to Individualize Frontline Therapy in Advanced Stages of Hepatocellular Carcinoma.
Drugs
; 83(12): 1091-1109, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37402062
18.
Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinoma.
bioRxiv
; 2023 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37425703
19.
Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of clinical data.
NPJ Precis Oncol
; 7(1): 29, 2023 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36959495
20.
Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma.
Front Oncol
; 13: 1184900, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38144528